| The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis K Dheda, T Gumbo, G Maartens, KE Dooley, R McNerney, M Murray, ... The lancet Respiratory medicine 5 (4), 291-360, 2017 | 695 | 2017 |
| Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage M Merker, C Blin, S Mona, N Duforet-Frebourg, S Lecher, E Willery, ... Nature genetics 47 (3), 242-249, 2015 | 575 | 2015 |
| Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing CRyPTIC Consortium and the 100,000 Genomes Project New England Journal of Medicine 379 (15), 1403-1415, 2018 | 320 | 2018 |
| Whole-genome-based Mycobacterium tuberculosis surveillance: a standardized, portable, and expandable approach TA Kohl, R Diel, D Harmsen, J Rothgänger, KM Walter, M Merker, ... Journal of clinical microbiology 52 (7), 2479-2486, 2014 | 215 | 2014 |
| Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland E Sanchez-Padilla, M Merker, P Beckert, F Jochims, T Dlamini, P Kahn, ... New England Journal of Medicine 372 (12), 1181-1182, 2015 | 208 | 2015 |
| Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients M Merker, TA Kohl, A Roetzer, L Truebe, E Richter, S Rüsch-Gerdes, ... PloS one 8 (12), e82551, 2013 | 157 | 2013 |
| Delamanid and Bedaquiline Resistance in Mycobacterium tuberculosis Ancestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan … H Hoffmann, TA Kohl, S Hofmann-Thiel, M Merker, P Beckert, K Jaton, ... American journal of respiratory and critical care medicine 193 (3), 337-340, 2016 | 154 | 2016 |
| A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study TM Walker, M Merker, AM Knoblauch, P Helbling, OD Schoch, ... The Lancet Infectious Diseases 18 (4), 431-440, 2018 | 152 | 2018 |
| The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ... The Lancet Microbe 3 (4), e265-e273, 2022 | 137 | 2022 |
| What is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi-and extensively drug-resistant tuberculosis J Heyckendorf, S Andres, CU Köser, ID Olaru, T Schön, E Sturegård, ... Antimicrobial agents and chemotherapy 62 (2), 10.1128/aac. 01550-17, 2018 | 124 | 2018 |
| The relationship between transmission time and clustering methods in Mycobacterium tuberculosis epidemiology CJ Meehan, P Moris, TA Kohl, J Pečerska, S Akter, M Merker, C Utpatel, ... EBioMedicine 37, 410-416, 2018 | 122 | 2018 |
| Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe M Hunt, P Bradley, SG Lapierre, S Heys, M Thomsit, MB Hall, KM Malone, ... Wellcome open research 4, 2019 | 117 | 2019 |
| Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia M Merker, M Barbier, H Cox, JP Rasigade, S Feuerriegel, TA Kohl, R Diel, ... Elife 7, e38200, 2018 | 116 | 2018 |
| Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in Northwest Ethiopia: new phylogenetic lineages found in Northwest Ethiopia B Tessema, J Beer, M Merker, F Emmrich, U Sack, AC Rodloff, S Niemann BMC infectious diseases 13, 1-11, 2013 | 103 | 2013 |
| LOC-SERS: a promising closed system for the identification of mycobacteria A Mühlig, T Bocklitz, I Labugger, S Dees, S Henk, E Richter, S Andres, ... Analytical chemistry 88 (16), 7998-8004, 2016 | 100 | 2016 |
| Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system E Schena, L Nedialkova, E Borroni, S Battaglia, AM Cabibbe, S Niemann, ... Journal of Antimicrobial Chemotherapy 71 (6), 1532-1539, 2016 | 82 | 2016 |
| Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex M Merker, TA Kohl, I Barilar, S Andres, PW Fowler, E Chryssanthou, ... Genome Medicine 12, 1-8, 2020 | 77 | 2020 |
| Whole genome sequencing for M/XDR tuberculosis surveillance and for resistance testing TM Walker, M Merker, TA Kohl, DW Crook, S Niemann, TEA Peto Clinical Microbiology and Infection 23 (3), 161-166, 2017 | 76 | 2017 |
| Bedaquiline-resistant tuberculosis: dark clouds on the horizon S Andres, M Merker, J Heyckendorf, B Kalsdorf, R Rumetshofer, A Indra, ... American journal of respiratory and critical care medicine 201 (12), 1564-1568, 2020 | 71 | 2020 |
| Emergence of low-level delamanid and bedaquiline resistance during extremely drug-resistant tuberculosis treatment S Polsfuss, S Hofmann-Thiel, M Merker, D Krieger, S Niemann, ... Clinical Infectious Diseases 69 (7), 1229-1231, 2019 | 71 | 2019 |
